Lupus Mutation May Unlock Targeted Drugs for Patient Subset

A new study provides definitive proof of one pathway that contributes to lupus, though it’s unclear how many patients with lupus are affected by this mechanism.

Related Keywords

New York ,United States ,Australia ,London ,City Of ,United Kingdom ,Canberra ,Australian Capital Territory ,Australian ,Ignacio Sanz ,Laura Lewandowski ,Carolag Vinuesa ,Noa Schwartz ,Global Health Disparities Unit ,Schwartz ,Montefiore Einstein Institute For Lupus Care ,Rheumatology Research Alliance ,Albert Einstein College Of Medicine ,National Institute Of Arthritis ,Francis Crick Institute ,Personalised Immunology ,Australian National University ,Albert Einstein College ,New York City ,Montefiore Einstein Institute ,Lupus Care ,Medscape Medical News ,Lupus Genomics ,National Institute ,Skin Disease ,Childhood Arthritis ,Published April ,Understanding Etiology ,Presented May ,Systemic Lupus Erythematosus ,Sale ,Lupus ,Autoimmune Disease ,Receptors ,Sjogrens Syndrome ,Sjogren Syndrome ,Arthritis ,Oint Inflammation ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Rheumatoid Arthritis ,A ,Activism ,Activist ,Coronavirus ,